A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid (Q44376248)

2 December 2017

A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid (English)

1 reference

2 December 2017

Sue K Cammarata

4

0 references

Joseph S Solomkin

object named as

Joseph S Solomkin

2

0 references

author name string

Samuel Eric Wilson

1

1 reference

2 December 2017

Vu Le

3

1 reference

2 December 2017

Jon B Bruss

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

The American Journal of Surgery

2 December 2017

1 reference

2 December 2017

185

1 reference

2 December 2017

4

1 reference

2 December 2017

369-375

1 reference

The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

APACHE—acute physiology and chronic health evaluation: a physiologically based classification system

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

inferred from DOI database lookup

7 January 2021

based on heuristic

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

A prediction rule to identify low-risk patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

7 January 2021

Soft tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Streptococcal infections of skin and soft tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Effect of antibiotics on toxin production and viability of Clostridium perfringens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Antibiotic effects on bacterial viability, toxin production, and host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

In vitro activities in new oxazolidinone antimicrobial agents against enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901411-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9610(02)01411-3

1 reference

2 December 2017

1 reference